Cyclins D1, D3, E, and A in vulvar carcinoma patients
- 1 June 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (3), 733-739
- https://doi.org/10.1016/j.ygyno.2005.03.025
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomasGynecologic Oncology, 2004
- Vulvar carcinomaCancer, 2002
- Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcomeThe Journal of Pathology, 2001
- Aberrant Expression of Cyclin D1 Is Associated with Poor Prognosis in Early Stage Cervical Cancer of the UterusGynecologic Oncology, 2001
- Over-expression of cyclin a is highly associated with early relapse and reduced survival in patients with primary breast carcinomasInternational Journal of Cancer, 2001
- Photodynamic Therapy of Vulvar Intraepithelial Neoplasia III Using Topically Applied 5-Aminolevulinic AcidGynecologic Oncology, 2001
- FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancersInternational Journal of Gynecology & Obstetrics, 2000
- Cyclin E-induced S phase without activation of the pRb/E2F pathway.Genes & Development, 1997
- Human papillomavirus in vulvar squamous‐cell carcinoma and in normal vulvar tissues: A search for a possible impact of HPV on vulvar cancer prognosisInternational Journal of Cancer, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958